• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Androgen receptor, treatment target for prostate cancer, imports into mitochondria

Bioengineer by Bioengineer
March 19, 2019
in Cancer
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In the mitochondria of the cell, the androgen receptor plays a novel role in regulating multiple mitochondrial processes

IMAGE

Credit: UAB

BIRMINGHAM, Ala. – Androgens, commonly known as male hormones, stimulate prostate cancer cells to grow. Thus, many of the drugs to target that cancer focus on stopping androgen biosynthesis or blocking the androgen receptor. This standard treatment is known as androgen deprivation therapy.

However, patients can develop resistance to this therapy and progress to androgen-independent, or castration-resistant, prostate cancer. This form is challenging to treat, which is one of the reasons prostate cancer is the second-leading cause of cancer deaths in men.

The androgen receptor, or AR, is a cellular protein in prostate tissues that is activated by binding androgen hormones like testosterone. The AR then moves to the cell nucleus to regulate the transcription of a host of genes. In prostate cancer, mutations in the AR can make it able to regulate transcription without the need to bind androgen.

Researchers at the University of Alabama at Birmingham have discovered a new function of the AR in prostate cells — the AR is imported into and localizes to mitochondria of the cell, where it plays a novel role in regulating multiple mitochondrial processes. Mitochondria, located in the cytosol of the cells, are the powerhouses of the cell. Many mitochondria in each cell work to produce approximately 90 percent of the energy cells need to survive.

The cell’s DNA genome is located inside the cell nucleus; but human mitochondria, with 37 genes, and the human nucleus, with 20,000 genes, engage in intricate, yet poorly understood, cross-talk that helps to fine-tune cellular metabolism.

The UAB study, led by Keshav K. Singh, Ph.D., professor of genetics in the UAB School of Medicine and a senior scientist in the O’Neal Comprehensive Cancer Center at UAB, provides a new element of mito-nuclear cross-talk that may be interesting because several studies have linked AR and mitochondria independently to prostate cancer risk, aggressiveness and outcome.

In detail, Singh and colleagues found that the AR localized to mitochondria in prostate tissues, and prostate cell lines, and it could be imported into mitochondria in vitro. Import of AR was dependent on a 36-amino-acid-long mitochondrial localization sequence that his team found on the AR; deletion of that sequence abolished import.

Using cell constructs that either knocked down or expressed AR, the researchers saw an inverse relationship between AR expression and mitochondrial DNA content and the amounts of a mitochondrial transcription factor called TFAM, which regulates mitochondrial DNA content.

Expression of AR reduced the expression of oxidative phosphorylation subunits, destabilized oxidative phosphorylation supercomplexes and reduced oxidative phosphorylation enzymatic activities. Moreover, mitochondrial impairment induced AR expression and increased its translocation into mitochondria.

###

Co-authors with Singh of the Journal of Biological Chemistry study, “Mitochondrial localization, import and mitochondrial function of the androgen receptor,” are Prachi Bajpai and Rajender Singh, UAB Department of Genetics; Emine Koc, Joan C. Edwards School of Medicine at Marshall University, Huntington, West Virginia; and Guru Sonpavde, Dana Farber Cancer Institute, Boston.

Support came from National Institutes of Health grant CA204430, a grant from the Mike Slive Foundation for prostate cancer research, and the Indo-US Science and Technology Forum.

At UAB, Singh holds the Joy and Bill Harbert Endowed Chair in Cancer Genetics.

Media Contact
Jeff Hansen
[email protected]

Original Source

https://www.uab.edu/news/research/item/10296-androgen-receptor-a-target-for-prostate-cancer-treatment-imports-into-mitochondria-and-plays-a-novel-role

Related Journal Article

http://dx.doi.org/10.1074/jbc.RA118.006727

Tags: cancerCell BiologyEndocrinologyInternal MedicineMedicine/HealthPhysiologyProstate CancerUrogenital System
Share12Tweet8Share2ShareShareShare2

Related Posts

Mini-Organs Uncover the Cervix’s Natural Defense Mechanisms

October 3, 2025

MCM2 Expression Predicts Type B Thymomas

October 3, 2025

MRI Radiomics Identifies Glioblastoma Survival Risks

October 3, 2025

Chidamide Boosts Lung Cancer Drug Sensitivity

October 3, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    88 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    67 shares
    Share 27 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Encapsulated Pseudomonas Controls Pistachio Gummosis Effectively

Illuminating the Future: Transforming Streetlamps into Electric Vehicle Chargers

Transforming Palm Waste into High-Performance CO₂ Absorbers: Malaysian Scientists Innovate with Agricultural Byproducts

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.